Organization
Nicoletta C Machin
1 clinical trial
Clinical trial
Prospective, Randomized Trial Comparing Recombinant Von Willebrand Factor (rVWF) Plus Tranexamic Acid vs. rVWF Alone to Reduce Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN TrialStatus: Recruiting, Estimated PCD: 2024-08-01